^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | T Acute Lymphoblastic Leukemia |
| Drug: | vincristine (Tubulin polymerization inhibitor) + prednisone (Steroid receptor agonist) + daunorubicin (Topoisomerase II inhibitor, DNA intercalator) + Oncaspar liquid (pegaspargase) (Asparagine depleter, Aspartate-ammonia ligase inhibitor) + nelarabine (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Preferred Regimens...(for T-ALL): daunorubicin, vincristine, prednisone, pegaspargase; and nelarabine.
